Reuters (12/12, Lapid) reports, “Children with obesity should receive intensive counseling to promote healthy diet and exercise habits starting at age 6, according to a draft recommendation” issued by the U.S. Preventive Services Task Force on Wednesday. In 2017, the USPSTF “had recommended … that screening for obesity start at age 6.” However, “research since then has shown the effectiveness of intensive behavioral interventions … for achieving a healthy weight and improving the quality of life for children and adolescents, the panel said.”

CNN (12/12, Christensen) reports, “The task force’s draft recommendations do not include weight loss medications or surgery, although it has looked at some research on those interventions.”

Related Links:

— “US panel recommends children with obesity start counseling from age 6,” Nancy Lapid, Reuters, December 12, 2023

HealthDay (12/12, Thompson) reports “gun advocates often claim that mental illness is the driving force behind mass shootings in the United States,” but a new study “argues that gun violence is more likely driven by the massive numbers of firearms available throughout the country, providing easy access.” The findingswere published in the American Journal of Medicine.

Related Links:

— “Firearm Access Drives High Rate of U.S. Gun Deaths, International Study Finds,” Dennis Thompson, HealthDay, December 12, 2023

Healio (12/12, Capaldo) reports, “Isotretinoin is not associated with an increased risk for suicide or psychiatric conditions on a population level, according to a study.” The researchers found “isotretinoin use was associated with a lower risk of suicide attempt at 2 to 4 years following treatment.” The findings were published in JAMA Dermatology.

Related Links:

— “Isotretinoin not associated with increased risk for suicide, psychiatric conditions,” Gabrielle Capaldo, Healio, December 12, 2023

HCPlive (12/11, Derman) reports, “Cannabis-based medicinal products (CBMPs) are associated with improving anxiety, sleep quality, and health-related quality of life in patients with” AD/HD, “according to a new study.” The research found that “with the CBMP treatment, less patients had to take concomitant” AD/HD “medication, with a reduction of 38.46% in lisdexamfetamine, 15% in methylphenidate, and 14.29% in dexamfetamine.” The findings were published in Neuropsychopharmacology Reports.

Related Links:

— “Cannabis Treatment Linked to Improving Quality of Life in ADHD Patients,” Chelsie Derman, HCPLive, December 11, 2023

Healio (12/11, Weldon) reports, “A rise in child suicides in the United States may be connected to the nation’s opioid crisis, according to a study.” The research “found 48,063 deaths designated as suicides for the 10- to 17-year-old population in the U.S. from 1980 to 2020.” According to the “study, areas of the U.S. that had more exposure to reformulated OxyContin [oxycodone hydrochloride] ‘experienced sharper growth in child suicide rates.’” The findings were published in Demography.

Related Links:

— “Study links ‘shocking’ rise in child suicide rates to opioid crisis,” Rose Weldon, Healio, December 11, 2023